ARCHIVES

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Oncologic Drug Committee Agrees That “Kitty Fight” With NCI Should Be Negotiated

November 28, 1975

In Brief: David Cole Named President of The Medical University of South Carolina

May 9, 2014

FDA Approves Evista for Breast Cancer Risk Reduction.

September 14, 2007

Anil Potti Resigns From Duke University

November 19, 2010

NCAB Subcommittee Suggests Comp Centers Must Have Core Grants

September 22, 1978

Collins Sworn In As NIH Director

September 4, 2009